Marc Engelhardt

Switzerland

Research Interests

Explore related searches

Professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Thomas Kaindl

Basilea Pharmaceutica International Ltd

SWITZERLAND

View details

Kamal Hamed

Chief Medical Officer

UNITED STATES

View details

Nicholas Turner

Assistant Professor

Duke University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marc Engelhardt

Research Interests

Explore related searches

Contact this professor

Articles (10)

Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance

Lisavanbulin (BAL101553), a novel microtubule inhibitor, plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastoma

Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies

Ceftobiprole for Treatment of Complicated <i>Staphylococcus aureus</i> Bacteremia.

Derazantinib: an investigational drug for the treatment of cholangiocarcinoma.

Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET).

A post hoc analysis of two Phase III trials showing the efficacy and tolerability of ceftobiprole in East Asian patients.

Efficacy and safety of ceftobiprole in patients aged 65 years or older: a <i>post hoc</i> analysis of three Phase III studies.

Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumours.

Ceftobiprole versus daptomycin in <i>Staphylococcus aureus</i> bacteremia: a novel protocol for a double-blind, Phase III trial.

Collaborators (3)

Thomas Kaindl

Kamal Hamed

Nicholas Turner

Make your next move.